Here are the latest broadly reported developments on meningococcal disease as of May 2026, with a focus on notable outbreaks and surveillance updates.
-
United Kingdom outbreak in Kent (March–April 2026): UKHSA reported an outbreak of invasive meningococcal disease linked to group B meningococcus in Kent, with several dozen cases and a couple of deaths during the initial phase. Early genetic analysis suggested the strain is in the group B clonal complex, and current vaccination efforts using MenB/Bexsero, along with antibiotic prophylaxis, were scaled up for students and staff in affected campuses. The outbreak prompted a targeted vaccination campaign for students in Kent and surrounding areas, and authorities emphasized that existing MenB vaccines should provide protective coverage against the identified strain.[3]
-
US surveillance and the surge in cases (2023–2025 context carried into 2026): In the United States, national CDC surveillance indicates fluctuations in meningococcal disease with periods of higher activity. Reports noted increases in certain years, including a rise in cases through 2024 and into 2025, though overall rates have historically been lower than many other bacterial respiratory infections in the short term. The CDC has continued to monitor trends and reinforce vaccination guidance for adolescents and high-risk groups, while noting that MenB vaccines are considered based on shared clinical decision-making rather than as a universal routine recommendation in some settings. These updates underscore ongoing vigilance for MenACWY and MenB vaccination strategies as part of routine preventive care for teens and people in congregate living situations.[4][5]
-
Public health context and protective measures: Public health authorities continue to rely on a combination of vaccination (including ACWY and MenB where indicated), rapid diagnostic testing, antibiotic prophylaxis for close contacts, and prompt outbreak investigations to control transmission. In the Kent outbreak, authorities also stressed collaboration with universities and NHS partners to ensure rapid access to vaccines and antibiotics for exposed populations. In the US, health agencies emphasize vaccination as a key preventive tool, while also preparing clinicians to recognize and treat meningococcal disease promptly due to its rapid and potentially severe course.[5][3][4]
Illustration: If you’d like, I can assemble a concise, up-to-date briefing with a timeline of the Kent outbreak and a quick reference table of current MenACWY and MenB vaccination recommendations by age group for your region.
Would you like me to pull the exact UKHSA and CDC updates into a summarized briefing with citations?
Sources
Find out about a meningococcal outbreak in the UK and about U.S. vaccination approaches for this infection. The UK Health Security Agency (UKHSA) is investigating an outbreak of meningococcal disease in Kent. As of March 25, 2026, the outbreak consisted of 20 confirmed laboratory cases, including two deaths. Two total notifications were under review. Early genetic analyses have identified group B meningococcus as the source of the outbreak. Importantly, the MenB vaccine, Bexsero, is...
www.chop.eduLatest updates from the ongoing outbreak.
www.gov.ukCDC tracks meningococcal disease cases nationally. U.S. disease rates are at historic lows.
www.cdc.govThe Centers for Disease Control has issued an alert warning for the public and healthcare providers to look out for meningococcal disease. The new strain has resulted in 143 cases since the start of…
people.comThere has been an increase of invasive meningococcal disease cases in the US, according to a health news alert issued by the CDC.
www.healthline.comThe CDC issued a health advisory alerting healthcare providers in response to a surge in invasive meningococcal disease.
www.fastcompany.comUpdates on respiratory illness and vaccine-preventable diseases
www.cdc.govAs of late March 2024, health officials in the US have recorded 143 cases of meningococcal disease, 101 of them caused by a strain of the bacteria Neisseria meningitidis known as sequence type (ST) 1466. The total number of cases of the disease represents a more than 75% increase over those reported...
jamanetwork.com